These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Alphavirus-based vaccines. Author: Lundstrom K. Journal: Curr Opin Mol Ther; 2002 Feb; 4(1):28-34. PubMed ID: 11883692. Abstract: Alphavirus vectors can be appliedfor vaccine production as naked RNA molecules, DNA plasmids or recombinant replication-deficient viral particles. The common feature for all these vectors is the alphavirus replicon, which is responsible for the strong RNA amplification in host cells enabling extreme transgene expression levels. Additionally, live replication-proficient virus has elicited reasonable immune responses. For many viral genes, humoral and cellular cytotoxic T-lymphocyte responses have been obtained. In other cases, monoclonal antibodies have been generated against the encoded antigen. Moreover, protection against challenges with lethal doses of virus has been achieved. Alphavirus vaccine applications have been further extended to models for prophylactic tumor therapy.[Abstract] [Full Text] [Related] [New Search]